Aytu Biopharma, Inc (AYTU) SEC Filings — 2025
15 SEC filings for Aytu Biopharma, Inc (AYTU) in 2025.
Filings
- Aytu Biopharma, Inc 8-K Filing — 8-K · Dec 10, 2025
- AYTU Swings to Profit on Warrant Gains, Revenue Dips 16% — 10-Q · Nov 13, 2025
- AYTU BioPharma Sets Dec. 10 Annual Meeting; Board Re-election, Auditor Ratification on Agenda — DEF 14A · Oct 24, 2025
- AYTU Bets on Antidepressant EXXUA Amidst $13.6M Loss — 10-K · Sep 23, 2025
- Aytu BioPharma Terminates Material Definitive Agreement — 8-K · Aug 7, 2025
- Aytu BioPharma Enters Material Definitive Agreement — 8-K · Jun 23, 2025
- Aytu Biopharma, Inc 8-K Filing — 8-K · Jun 17, 2025
- Aytu Biopharma Files 8-K Report — 8-K · Jun 9, 2025
- Aytu BioPharma Acquires NovaLead Pharma Assets — 8-K · Jun 6, 2025
- AYTU BioPharma Amends S-1 for Continuous Securities Offering — S-1/A · Jun 5, 2025
- AYTU Biopharma Files S-1 for Equity Offering Amidst Warrant Restructuring — S-1 · Jun 2, 2025
- Aytu BioPharma Files 8-K: Director Changes, Officer Updates — 8-K · May 21, 2025
- Aytu BioPharma Files 10-Q, Reports Q3 2025 Financials — 10-Q · May 14, 2025
- Aytu BioPharma Files Definitive Proxy Statement — DEF 14A · Mar 28, 2025
- Aytu BioPharma Files 10-Q, Reports Q2 Revenue — 10-Q · Feb 12, 2025